| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |